Location
3 Locations
Compensation
$122k–$213k USD
Posted
2 days ago
Market range · company + function + seniority
p25 · target · p75 · n=28
Posted $213k · above the band
Tailor your résumé to this role in 30 seconds.
Free account · ATS keyword check · per-job bullet rewrite by Claude.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function:
FinanceJob Sub Function:
Finance Business PartnersJob Category:
People LeaderAll Job Posting Locations:
Raritan, New Jersey, United States of America, Spring House, Pennsylvania, United States of America, Titusville, New Jersey, United States of AmericaJob Description:
Johnson & Johnson is recruiting for Senior Finance Manager, Global Oncology R&D and Commercial, Heme DAS. This position can be based in New Jersey (Raritan, Titusville) or Pennsylvania (Spring House) and may require up to 10% domestic travel.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/
Position Overview
Johnson & Johnson Innovative Medicine is recruiting for Senior Finance Manager, Global Oncology R&D and Commercial, Heme DAS.
The Sr Manager will provide financial leadership, support, and analysis for the early and late-stage development compounds within the Oncology Therapeutic Area Heme Disease Area Stronghold (DAS). The role actively collaborates with Oncology Leaders and other Business Partners to align financial targets, address business issues, and analyze the value creation of investment decisions. Additionally, the Sr Manager works closely with Business Development and the Johnson & Johnson Innovation Centers in support of External Innovation and L&A/M&A projects. In addition, the position will have 1 Manager and 2 Sr. Financial Analysts under supervision.
Responsibilities
Qualifications
Other:
Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.
Johnson and Johnson is committed to providing an interview process that is inclusive of our applicants’ needs. If you are an individual with a disability and would like to request an accommodation, please email the Employee Health Support Center (ra-employeehealthsup@its.jnj.com) or contact AskGS to be directed to your accommodation resource.
#Li-Hybrid
Required Skills:
Preferred Skills:
Budget Management, Data Quality, Developing Others, Execution Focus, Expense Controls, Financial Analysis, Financial Forecasting, Financial Reports, Financial Risk Management (FRM), Inclusive Leadership, Internal Controls, Leadership, Program Management, Risk Management, Sarbanes-Oxley Compliance, Succession Planning, Tactical Planning, Vendor Management
The anticipated base pay range for this position is :
$122,000- $212,750Additional Description for Pay Transparency:
The Company maintains highly competitive, performance-based compensation programs. Under current guidelines, this position is eligible for an annual performance bonus in accordance with the terms of the applicable plan. The annual performance bonus is a cash bonus intended to provide an incentive to achieve annual targeted results by rewarding for individual and the corporation’s performance over a calendar/performance year. Bonuses are awarded at the Company’s discretion on an individual basis. Employees and/or eligible dependents may be eligible to participate in the following Company sponsored employee benefit programs: medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance. Employees may be eligible to participate in the Company’s consolidated retirement plan (pension) and savings plan (401(k)). This position is eligible to participate in the Company’s long-term incentive program. Employees are eligible for the following time off benefits: Vacation – up to 120 hours per calendar year Sick time - up to 40 hours per calendar year Holiday pay, including Floating Holidays – up to 13 days per calendar year of Work, Personal and Family Time - up to 40 hours per calendar year Additional information can be found through the link below. http://www.careers.jnj.com/employee-benefits The compensation and benefits information set forth in this posting applies to candidates hired in the United States. Candidates hired outside the United States will be eligible for compensation and benefits in accordance with their local market.More open roles at Johnson & Johnson
Hiring velocity, headcount trend, and every open posting on one page.
Open postings ranked by description similarity — useful if this role isn't quite right.